Purchase Order 75N95024P00469
Award Date 8/16/24
Potential Completion Date 12/6/24
Potential Value $45K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), Early Translation Branch (ETB), to Cellmosaic, Inc., a small disadvantaged, woman-owned business, for the synthesis of compound '961. The contract has a ceiling value of $24,738.00 and a period of performance ending on September 8, 2025. The contract was awarded on September 9, 2024 and does not have a set-aside designation. The purpose of the contract is to support the...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to AAT Bioquest, Inc., a minority-owned, for-profit, woman-owned small business, and Asian-Pacific American-owned manufacturer of goods. The contract, valued at $161,032.00, is for products or services related to the NIH's mission of accelerating the translation of research to improve human health. The contract does not have a set-aside designation and...
- This $15,735 firm fixed-price purchase order was awarded by the National Institute of Dental and Craniofacial Research (NIDCR), a component of the National Institutes of Health (NIH), to MedChemExpress LLC, a New Jersey-based provider of chemical compounds and research materials. The contract is for chemical synthesis services to produce one chemical probe compound for delivery to NIDCR. No set-aside designation was used. MedChemExpress has previously served as both a prime contractor and...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $19,800 firm fixed price purchase order to Karebay Biochem Inc., a for-profit small business, to synthesize 200 grams of compound NCGC00413972. This order supports NIH's biomedical research programs, particularly in the areas of drug discovery and infectious disease. Karebay Biochem has received multiple prior purchase orders from NIH entities to...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), to Life Chemicals USA, Inc. for $50,697.50. The order is for a screening compound set of 3,750 small molecules to be used in the Genesis screening library. The purchase was made through a non-competitive combined synopsis/solicitation process. There was no set-aside designation for this award. The award has a...
- This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting...
- The National Institute on Drug Abuse awarded a $101,000 firm fixed-price purchase order to Chemogenics Biopharma, LLC on September 16, 2025, for synthesis and bioanalytical analysis services supporting the National Center for Advancing Translational Sciences (NCATS) Early Translational Branch Chemistry Program. The contract, which extends through July 15, 2026, is performable in Durham, North Carolina. This procurement does not utilize a small business set-aside designation. The work involves...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services (HHS), to American Biochemicals Inc. The contract is for the provision of 1 gram of ML246 (metarrestin) compound for $86,000.00. The contract does not have a set-aside designation. American Biochemicals Inc. is a minority-owned, small disadvantaged business that specializes in small molecule design, optimization,...
- This is a $249,500 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a small business. The contract is for synthesis and bioanalytical analysis support services related to the therapeutic areas of the microbiome, neurodegeneration, and addiction. The services will augment existing medicinal chemistry campaigns within the National Center for Advancing Translational...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...